Updated version 2 - According to the Financial Times, McKesson and CD&R are about to finalize a deal worth more than 5 billions dollars to acquire Option Care.
路透社2026/10/05 20:57The second paragraph has been updated with shareholding information, and the full background section has also been adjusted accordingly. Reuters, October 5th – According to the Financial Times, citing sources on Monday, U.S. pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are close to reaching an agreement to acquire infusion service provider Option Care Health in a deal valued at over $5 billion (including debt). Following this news, Option Care's share price rose by 21% in after-hours trading. The report noted that the deal could be announced as early as Tuesday, but negotiations could still fall through. This acquisition would be the latest transaction for McKesson as it seeks to expand its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about $2.25 billion, as part of its multi-year effort to strengthen high-growth business segments. Option Care provides infusion services, allowing patients to receive intravenous therapy at home or in outpatient settings without having to go to a hospital. McKesson has been reshaping its business portfolio by divesting non-core assets and investing in areas such as oncology and specialty care. Thanks to the growth of its specialty pharmaceutical distribution business and contributions from acquisitions, its oncology and multi-specialty business segments saw revenue grow by 33% in the latest quarter. McKesson, CD&R, and Option Care did not immediately respond to Reuters’ requests for comment on this report.
Information on shares has been added in the second paragraph, and full background sections have been adjusted accordingly.
Reuters, October 5 - According to The Financial Times, citing people familiar with the matter on Monday, US pharmaceutical distributor McKesson (MCK.N) and private equity firm Clayton Dubilier & Rice are close to reaching a deal to acquire infusion services provider Option Care Health in a transaction valued at more than $5 billion, including debt.
Following the news, Option Care’s share price rose by 21% in after-hours trading.
The report said the deal could be announced as soon as Tuesday, though the negotiations could still fall apart.
This acquisition would be McKesson's latest deal as it seeks to expand its healthcare services portfolio. In August this year, the company agreed to acquire Precision Medicine Group for about $2.25 billion (link), as part of its multi-year efforts to strengthen its high-growth business segments.
Option Care provides infusion services, enabling patients to receive intravenous therapy at home or in other outpatient settings without having to go to a hospital.
McKesson has been reshaping its portfolio by divesting non-core assets and investing in fields such as oncology and specialty care (link).
Driven by growth in its specialty drug distribution business and contributions from acquisitions, revenue from its oncology and multi-specialty segment rose 33% in the latest fiscal quarter.
McKesson, CD&R, and Option Care did not immediately respond to Reuters’ request for comment regarding the report.
(To facilitate non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack desired context, Reuters does not guarantee the accuracy of the automated translations, which are provided solely for reader convenience. Reuters accepts no liability for any damage or loss resulting from use of the automated translation function.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UANI: US sanctions caused dozens of Iranian oil tankers to be stranded, with at least 50 still near Iran
(1) According to the United Against Nuclear Iran (UANI), the U.S. blockade of Iran has resulted in dozens of fully loaded oil tankers stranded along Iran's coast, while some other tankers are anchored outside the Persian Gulf near Sri Lanka. (2) In its routine shipping update released on October 5, UANI stated that at least 50 oil tankers carrying Iranian oil remain stranded near Iran, which is largely unchanged from two months ago. These ships are mainly loaded with crude oil, although some are transporting petroleum products and liquefied petroleum gas. (3) UANI also noted that, in other waters, some empty vessels are “anchored at various locations in the Indian Ocean and Pacific region due to the U.S. blockade, rather than returning to Iranian ports.” Currently, 20 Iran-flagged vessels are anchored near Sri Lanka, and 1 is located near Oman.
Concerns about the spread of French government bond risks intensify, making it difficult to stop the euro’s decline
(1) The euro continues to weaken, becoming the latest warning sign as France's soaring borrowing costs spread to the broader eurozone market. On Monday, the euro fell below 1.12 against the US dollar, hitting a 17-month low, and also dropped significantly against the British pound, Swiss franc, and Japanese yen. (2) The French government is pushing a controversial 2027 budget plan aimed at reducing the fiscal deficit and controlling record debt. However, deep divisions in parliament and parties preparing for next year's presidential election make this goal difficult to achieve. Investors are selling French government bonds and shifting to German bunds for safety. The yield spread between French and German bonds has reached its widest level since the eurozone debt crisis of 2010–2012, raising market concerns about the risk spreading to other eurozone countries. (3) Analysts state that the factors that supported the euro this summer have disappeared. Previous market expectations that the energy shock would be brief and that the US intended to push the dollar lower have faded. According to Bank of America, every 10 basis point widening of the France-Germany spread could lower the euro/dollar by 0.4%; Goldman Sachs says this effect could intensify significantly during periods of severe market stress. (4) Andreas König, Global Head of FX at AXA Investment Managers, noted that the euro/dollar pair is usually more influenced by US news, but Europe is also having an impact this time; he does not expect a turnaround in the medium term and continues to overweight the US dollar. CFTC positions show traders are bearish on the euro, and the three-month euro risk reversal indicator fell last Friday to its most bearish level since 2024. (5) Analysts suggest the euro may test $1.10; Societe Generale's Juckes also highlights the euro's vulnerability to the yen and Swiss franc, noting that the euro has fallen nearly 4% against the yen in September.
Nvidia's long-term supply commitment rises to $279 billion, securing 37.3% of HBM supply
According to the latest estimates from Morgan Stanley, Nvidia has secured approximately 37.3% of the global high-bandwidth memory (HBM) supply for 2027. Its long-term supply commitments have surged from $119 billion in the previous quarter to $279 billion (about 1.87 trillion RMB). Nvidia’s supply commitments are not evenly distributed. According to the financial report, around $92 billion will mature during the remainder of fiscal year 2027, $87 billion in fiscal 2028, and $88 billion in fiscal 2029. The cost per GB of HBM4 has jumped from $17–18 during the HBM3e era to $31–32, nearly doubling. Bernstein predicts that HBM4 pricing may further rise to $53 per GB in 2027, and UBS estimates that the average HBM price overall in 2027 will be about 79% higher than in 2026. It should be noted that the production capacity of the three major memory manufacturers has already been fully booked in advance. Micron CEO Sanjay Mehrotra stated clearly during the October 1 earnings call that the majority of HBM supply in 2027 has already been secured via agreements, and there is currently no sign of a supply-demand balance being restored. Samsung also stated that customers have pre-ordered 2027 demand in advance, and the supply gap is expected to further widen compared to 2026.
Trump says high oil prices in the U.S. are a small price to pay for security
According to Al Jazeera, former U.S. President Donald Trump repeatedly emphasized that the higher prices paid by American consumers at gas stations are a “small price to pay for maintaining world security and ensuring national safety.” Trump made these remarks during a campaign rally in Grand Island, Nebraska. While claiming that current oil prices are lower than those during the Biden administration, Trump also stated that gasoline prices would drop to below $1.85 per gallon (approx. 3.8 liters) “in a very short time.” He reiterated that this could happen before the November 3rd midterm elections or shortly thereafter. Trump said, “Please understand, we are saving this country… and indeed the whole world from what could be the most severe disaster in history,” and again stressed that the United States would never allow Iran to possess nuclear weapons.